Start With an Implant-Labeling Review Record
Before a consultation, use the implant materials as a document-audit set rather than as a general procedure summary. Breast augmentation is intended to increase breast size, and implant-based augmentation involves placing implants under breast tissue or chest muscles. The audit question is narrower: can you identify what the materials say about the proposed device, what each document is for, and which terms still need clarification?
Collect the benefit-and-risk labeling, boxed warning information, patient decision checklist, manufacturer patient labeling, and device card for the implant under discussion. Mark each document’s title, device details, warnings, risks, and unresolved terms. The FDA states that breast implants are not lifetime devices, so the record should also show where the materials address monitoring and the possibility of additional procedures.
Do not use the documents to select an implant, placement, incision, or surgical plan on your own. Use them to make the later discussion more precise and to distinguish information that is device-specific from decisions that require an individualized clinical assessment.
Record What Labeling Cannot Choose for You
A labeling record should include a clearly marked section called “questions the materials cannot answer.” Device information can describe an implant, but it cannot establish whether a particular surgical plan fits an individual.
Implant insertion and positioning are individualized based on factors such as implant type, the degree of enlargement desired, body type, and the surgeon’s recommendations. Potential incision locations include the areolar edge, the fold under the breast, and the armpit. These are discussion topics, not options to select from a general article. The American Society of Plastic Surgeons notes that a belly-button approach is associated with a higher complication rate.
Write your own questions beside, rather than inside, the device materials:
- What change am I hoping to discuss?
- Which implant characteristics, placement, and incision are being considered, and why?
- What features of my anatomy need professional assessment?
- What would the proposed approach not change?
Also separate volume from breast position. Implants do not prevent breast sagging, so a lift may be discussed when sagging is a concern. Whether augmentation alone addresses a particular concern cannot be settled by a label, photograph, or another person’s experience.
Use Your Goals to Read Benefits and Limits Carefully
Before reading a proposed implant’s materials, add a short statement of what you want to discuss. Breast augmentation is intended to increase breast size, but that general purpose does not establish that every appearance concern will be addressed.
Use a second note headed “limits that matter to me.” For example, breast implants do not stop breast sagging, and changes in the breasts and body over time can affect appearance. If position is an important concern, record it as a topic for individualized assessment rather than assuming added volume will resolve it.
Future breastfeeding priorities also belong in this note. Breast augmentation can affect nerves and ducts involved in lactation. Cleveland Clinic notes that implant placement and incision location can matter for future milk production. This does not predict an individual experience; it identifies a priority that should be raised before a plan is selected.
This part of the record helps distinguish a hoped-for change from questions that need clinical explanation. It is a way to read benefit information carefully, not a way to forecast a personal result.
Build the Record From Required Implant Materials
Audit Each Document Against the Others
Start with the benefit-and-risk labeling and boxed warning. Record the proposed device’s identifying details and copy the main benefits, warnings, risks, and limitations into separate notes. Do not combine a general implant statement with a device-specific statement unless the materials support that connection.
Next, review the patient decision checklist. Under FDA requirements, the checklist is reviewed with the prospective patient and signed by the patient and implanting physician. Mark each topic that is clear and each term that needs explanation. The checklist is an informed-discussion document, not a personal risk calculation.
Then compare the manufacturer’s patient labeling and educational materials with the earlier notes. Look for information that adds detail, narrows a statement, or identifies a device-specific qualification. If a term appears inconsistent or unclear, preserve both references in the record and bring the discrepancy to the surgeon rather than resolving it yourself.
Finally, record what the device card identifies, including the implant’s serial or lot number and style and size. Keep the card with the reviewed labeling so the device information remains accessible later. The FDA advises reading the manufacturer’s materials and discussing questions with the surgeon before deciding.
A completed audit should answer three limited questions: which documents were reviewed, which statements appear to describe the proposed device, and which points require clarification. It should not become a substitute for examination or an individualized surgical plan.
Add Device Risks to the Record Without Self-Calculating
FDA approval reflects testing for reasonable assurance of safety and effectiveness; it does not eliminate implant risks. Your individual likelihood of a complication cannot be determined from an article, but the known categories should be part of the decision before surgery.
The FDA identifies capsular contracture, reoperation, and implant removal among the most common local complications and adverse outcomes. It also identifies rupture or deflation, wrinkling, asymmetry, scarring, pain, and infection at the incision site. For silicone gel-filled implants, rupture can be silent, meaning it may occur without symptoms.
Some risks may require further evaluation or treatment. The FDA describes breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL, as a risk associated with implants that can occur in the breast or surrounding scar capsule; it is not breast cancer. The FDA also says that cases of squamous cell carcinoma and various lymphomas in the capsule around implants may be rare.
These facts do not tell you what will happen in your case. They do establish why informed consent should be more than a general statement that surgery has risks. Ask for an explanation of the risks associated with the proposed implant, what symptoms or changes should prompt contact, and what further evaluation or treatment could be considered if a complication occurs.
A reasonable decision does not require pretending that risks are absent. It requires understanding which risks are known, which questions remain individualized, and whether you are prepared to accept the possibility of additional care.
One way to keep this discussion useful is to separate three kinds of questions. First, ask which complications and warnings are identified in the labeling for the specific device under consideration. Second, ask what changes or symptoms the treating team would want you to report and what evaluation may follow. Third, ask which aspects of your health history, anatomy, and proposed plan still need individualized assessment. This separation matters because a general risk list can identify subjects for discussion, but it cannot predict whether a complication will occur for you or determine how a clinician would manage it.
If an explanation leaves you unsure whether a point is a known device risk, a monitoring issue, or an individualized concern, write it down for clarification before making a decision. Understanding the category of a question can make manufacturer materials and the patient decision checklist more useful without turning them into a personal risk calculation.
Record the Follow-Up Responsibilities Attached to a Device
The device card and follow-up information should form the long-term section of the review record. The FDA states that breast implants require monitoring for as long as they remain in place, and that the likelihood of complications and adverse outcomes rises the longer implants are in place.
For silicone gel-filled implants, a clinician may recommend periodic MRI or ultrasound screening for rupture and other complications. Record the questions you need answered about the proposed device: what monitoring may be considered, when it may be considered, who will explain the plan, and how the plan will be documented.
The device card contains information specific to an implant, including its serial or lot number and style and size. Keep it with the labeling and postoperative information so the information remains accessible later. The FDA advises promptly contacting a surgeon or health care provider about abnormal changes in the breasts or implants.
A completed record does not supply a universal follow-up schedule. It helps you recognize that device information remains relevant after surgery and gives you a focused list for a clinician-led follow-up discussion.
Keep Recovery Questions Separate From Device Information
Keep recovery logistics in a separate section of the record rather than treating them as device-labeling details. Preparation may include testing, medication review or adjustments, smoking cessation, and avoiding certain substances as directed by the surgical team. Do not make medication or substance changes from a general checklist alone.
After surgery, support may include gauze dressings and an elastic bandage or support bra. Instructions vary, including directions about support garments and incision care. The treating plastic surgeon’s specific postoperative instructions are the directions to follow.
Use this page to capture practical questions for a consultation:
- Which preparation steps would need to be discussed in light of my medical history and current medications?
- What garment use, incision care, support, and activity questions should I ask about?
- What follow-up arrangements would be relevant to the proposed plan?
- Whom should I contact if I have a recovery question?
This is not a recovery schedule or a promise about healing. It is a way to determine whether you understand the practical responsibilities that would accompany an individualized surgical plan.
Use the Completed Record to Decide Whether to Seek Discussion
Use the Audit to Prepare a Focused Discussion
Bring the reviewed documents and a short discrepancy list to a consultation. Ask which labeling applies to the implant being discussed, how the patient decision checklist will be reviewed, what the boxed warning means in this context, and what information the device card will contain.
Also mark questions that the documents cannot answer, including how your goals and anatomy affect the proposed plan, what placement or incision options may be considered, how recovery instructions would be individualized, and what monitoring or future procedures may need discussion. The American Society of Plastic Surgeons identifies asking whether a surgeon is certified by the American Board of Plastic Surgery as an important consultation question.
The purpose of this audit is not to produce a recommendation. It is to make the source documents easier to compare and the unresolved questions easier to explain. If you want an individualized discussion of the audited materials and your goals, move from general education to a personalized assessment.
Breast Augmentation Consultation FAQ
How is the implant plan chosen?
The choice depends on factors like the amount of enlargement desired, body type, implant characteristics, and the surgeon’s recommendations. A consultation is where placement and incision options are discussed in relation to your goals.
What should I know if I want to breastfeed in the future?
Mention that early in the discussion. Augmentation can affect the nerves and ducts involved in lactation, and implant placement and incision location may matter, so this priority should be reviewed before a plan is selected.
What are the main risks to discuss before deciding?
Some silicone implant ruptures can happen without symptoms, so risks should be reviewed carefully.
Do breast implants need long-term follow-up?
Yes. Discuss the follow-up plan for the device being considered with the surgeon.
What should I expect during recovery planning?
Preparation may include testing, medication review or adjustments, smoking cessation, and avoiding certain substances if directed by the surgical team. After surgery, you may be instructed to use a support garment and follow specific incision-care directions.
What questions are useful to bring to a consultation?
Ask which implant is being proposed, what labeling materials you should read, what the device card will show, how the decision checklist will be reviewed, whether the plan addresses sagging or breastfeeding goals, and what follow-up or monitoring may be needed.
Leave a Reply